Adaptive and Behavioral Phenotype in Pediatric 22q11.2 Deletion Syndrome: Characterizing a High-Risk Neurogenetic Copy Number Variant
Abstract
1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Procedures
2.2.1. Sociodemographic and Clinical Variables
2.2.2. Cognition, Intellectual Assessment, and Adaptive Functioning
2.2.3. Behavioral Indicators Assessment
2.3. Data Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Appendix A
Appendix A.1. Univariate Linear Regression Analyses Between Sociodemographic, Clinical Variables and FSIQ—Only p < 0.200 (n = 34)
| Variables | B | SE | p | CI 95% |
|---|---|---|---|---|
| FSIQ | ||||
| Sociodemographic variables | ||||
| Age | 1.54 | 1.01 | 0.142 | (−0.54/3.63) |
| Type of school | 14.68 | 5.94 | 0.021 | (2.46/26.90) |
| Literate | 14.13 | 7.99 | 0.089 | (−2.35/30.62) |
| Caretaker years of schooling | 5.71 | 3.39 | 0.103 | (−1.25/12.67) |
| Family social class | −5.66 | 2.83 | 0.056 | (−11.46/0.17) |
| Clinical variables | ||||
| Developmental delay | −13.56 | 7.34 | 0.077 | (−28.70/1.58) |
| Neurological problems | −14.06 | 7.89 | 0.091 | (−30.56/2.45) |
| GAF | ||||
| Sociodemografic variables | ||||
| Special educational support | −9.43 | 5.52 | 0.098 | (−20.70/1.88) |
| Family social class | −5.29 | 2.85 | 0.073 | (−11.10/0.52) |
| Clinical variables | ||||
| Health problems | −17.13 | 7.30 | 0.026 | (−32.05/−2.22) |
| Developmental delay | −10.95 | 7.84 | 0.173 | (−26.99/5.10) |
| Use of psychotropic medication | −8.36 | 6.03 | 0.176 | (−20.68/3.97) |
Appendix A.2. Univariate Linear Regression Analyses Between Sociodemographic, Clinical Variables and CBCL—Only p < 0.200 (n = 34)
| Variant | B | SE | p | CI 95% |
|---|---|---|---|---|
| Anxious | ||||
| Sociodemographic variables | ||||
| Gender | 6.38 | 3.41 | 0.073 | (−0.63/13.38) |
| Family social class | −3.57 | 1.70 | 0.046 | (−7.06/−0.07) |
| Clinical variables | ||||
| Inherited deletion | −9.46 | 4.78 | 0.059 | (−19.29/0.38) |
| Neurological problems | −6.04 | 4.52 | 0.171 | (−14.91/2.83) |
| Withdrawn | ||||
| Sociodemographic variables | ||||
| Age | 1.95 | 0.83 | 0.026 | (0.25/3.66) |
| Clinical variables | ||||
| Congenital heart disease | −14.57 | 5.94 | 0.022 | (−26.86/−2.29) |
| Use of psychotropic medication | −7.83 | 5.75 | 0.185 | (−19.67/4.00) |
| Somatic | ||||
| Sociodemographic variables | ||||
| Age | 0.96 | 0.65 | 0.154 | (−0.38/2.30) |
| Literate | 11.66 | 4.90 | 0.026 | (1.54/21.77) |
| Clinical variables | ||||
| Inherited deletion | −11.79 | 5.32 | 0.035 | (−22.71/−0.87) |
| Pregnancy problems | −7.52 | 4.45 | 0.104 | (−16.72/1.68) |
| Neonatal complications | −5.62 | 4.07 | 0.181 | (−14.02/2.79) |
| Neurological problems | −9.40 | 4.28 | 0.040 | (−18.32/−0.47) |
| Social Problems | ||||
| Clinical variables | ||||
| Inherited deletion | 8.28 | 5.68 | 0.157 | (−3.40/19.96) |
| Congenital heart disease | −8.56 | 4.04 | 0.045 | (−16.93/−0.20) |
| Thought Problems | ||||
| Sociodemographic variables | ||||
| Gender | 7.40 | 2.88 | 0.016 | (1.47/13.32) |
| Type of school | 5.28 | 3.17 | 0.108 | (−1.23/11.79) |
| Family social class | −4.79 | 1.34 | 0.001 | (−7.54/−2.03) |
| Clinical variables | ||||
| Health problems | 5.67 | 4.42 | 0.212 | (−3.43/14.76) |
| Attention Problems | ||||
| Sociodemographic variables | ||||
| Gender | 10.75 | 3.51 | 0.005 | (3.53/17.97) |
| Clinical variables | ||||
| Congenital heart disease | −7.64 | 4.69 | 0.117 | (−17.33/2.06) |
| Neurological problems | −9.50 | 5.91 | 0.093 | (−20.75/1.75) |
Appendix A.3. Univariate Linear Regression Analyses Among Psychometric Outcomes—Only p < 0.200 (n = 34)
| Variables | B | SE | p | CI 95% |
|---|---|---|---|---|
| GAF | ||||
| Social Problems | −0.71 | 0.33 | 0.042 | (−1.40/−0.03) |
| Adaptive Functioning—Communication | ||||
| Social Problems | −0.51 | 0.29 | 0.095 | (−1.19/0.10) |
| Adaptive Functioning—Socialization | ||||
| Social Problems | −0.79 | 0.42 | 0.074 | (−1.66/0.08) |
| Attention Problems | −0.53 | 0.41 | 0.199 | (−1.37/0.30) |
References
- Babcock, M.; Pavlicek, A.; Spiteri, E.; Kashork, C.D.; Ioshikhes, I.; Shaffer, L.G.; Jurka, J.; Morrow, B.E. Shuffling of genes within low-copy repeats on 22q11 (LCR22) by Alu-mediated recombination events during evolution. Genome Res. 2003, 13, 2519–2532. [Google Scholar] [CrossRef][Green Version]
- Cirillo, A.; Lioncino, M.; Maratea, A.; Passariello, A.; Fusco, A.; Fratta, F.; Monda, E.; Caiazza, M.; Signore, G.; Esposito, A.; et al. Clinical manifestations of 22q11.2 deletion syndrome. Heart Fail. Clin. 2022, 18, 155–164. [Google Scholar] [CrossRef]
- McDonald-McGinn, D.M.; Sullivan, K.E.; Marino, B.; Philip, N.; Swillen, A.; Vorstman, J.A.S. 22q11.2 deletion syndrome. Nat. Rev. Dis. Primers 2015, 1, 15071. [Google Scholar] [CrossRef]
- Shprintzen, R.J.; Higgins, A.M.; Antshel, K.; Fremont, W.; Roizen, N.; Kates, W. Velo-cardio-facial syndrome. Curr. Opin. Pediatr. 2005, 17, 725–730. [Google Scholar] [CrossRef]
- Radoeva, P.D.; Fremont, W.; Antshel, K.M.; Kates, W.R. Longitudinal study of premorbid adjustment in 22q11.2 deletion syndrome and association with psychosis. Dev. Psychopathol. 2017, 29, 235–248. [Google Scholar] [CrossRef] [PubMed]
- Schneider, M.; Debbané, M.; Bassett, A.S.; Chow, E.W.C.; Fung, W.L.A.; van den Bree, M.; Owen, M.; Murphy, K.C.; Niarchou, M.; Kates, W.R.; et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome. Am. J. Psychiatry 2014, 171, 627–639. [Google Scholar] [CrossRef]
- Fabbro, A.; Rizzi, E.; Schneider, M.; Debbané, M.; Eliez, S. Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome. Eur. Child Adolesc. Psychiatry 2012, 21, 379–385. [Google Scholar] [CrossRef] [PubMed]
- Gothelf, D.; Schneider, M.; Green, T.; Debbané, M.; Frisch, A.; Glaser, B.; Zilkha, H.; Schaer, M.; Weizman, A.; Eliez, S. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome. J. Am. Acad. Child Adolesc. Psychiatry 2013, 52, 1192–1203. [Google Scholar] [CrossRef] [PubMed]
- Fiksinski, A.M.; Schneider, M.; Murphy, C.M.; Armando, M.; Vicari, S.; Canyelles, J.M.; Gothelf, D.; Eliez, S.; Breetvelt, E.J.; Arango, C.; et al. Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome. Am. J. Med. Genet. A 2018, 176, 2182–2191. [Google Scholar] [CrossRef]
- Swillen, A.; Moss, E.; Duijff, S. Neurodevelopmental outcome in 22q11.2 deletion syndrome and management. Am. J. Med. Genet. A 2018, 176, 2160–2166. [Google Scholar] [CrossRef]
- De Smedt, B.; Devriendt, K.; Fryns, J.P.; Vogels, A.; Gewillig, M.; Swillen, A. Intellectual abilities in a large sample of children with velo-cardio-facial syndrome: An update. J. Intellect. Disabil. Res. 2007, 51, 666–670. [Google Scholar] [CrossRef]
- Jacobson, C.; Shearer, J.; Habel, A.; Kane, F.; Tsakanikos, E.; Kravariti, E. Core neuropsychological characteristics of children and adolescents with 22q11.2 deletion. J. Intellect. Disabil. Res. 2010, 54, 701–713. [Google Scholar] [CrossRef]
- Swillen, A.; McDonald-McGinn, D. Developmental trajectories in 22q11.2 deletion syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 2015, 169, 172–181. [Google Scholar] [CrossRef]
- Pimenta, L.S.E.; Mello, C.B.; Soares, D.C.Q.; Dantas, A.G.; Melaragno, M.I.; Kulikowski, L.D.; Kim, C.A. Intellectual performance profile of Brazilian children and adolescents with 22q11.2 deletion syndrome. Estud. Psicol. 2023, 36, e210082. [Google Scholar]
- Zhao, Y.; Guo, T.; Fiksinski, A.; Breetvelt, E.; McDonald-McGinn, D.M.; Crowley, T.B.; Diacou, A.; Schneider, M.; Eliez, S.; Swillen, A.; et al. Variance of IQ is partially dependent on deletion type among 22q11.2 deletion syndrome subjects. Am. J. Med. Genet. A 2018, 176, 2172–2181. [Google Scholar] [CrossRef]
- Antshel, K.M.; Shprintzen, R.; Fremont, W.; Higgins, A.M.; Faraone, S.V.; Kates, W.R. Cognitive and psychiatric predictors of psychosis in velocardiofacial syndrome. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49, 333–344. [Google Scholar] [CrossRef] [PubMed]
- Moss, E.M.; Batshaw, M.L.; Solot, C.B.; Gerdes, M.; McDonald-McGinn, D.M.; Driscoll, D.A.; Emanuel, B.S.; Zackai, E.H.; Wang, P.P. Psychoeducational profile of the 22q11.2 microdeletion. J. Pediatr. 1999, 134, 193–198. [Google Scholar] [CrossRef]
- Niklasson, L.; Rasmussen, P.; Óskarsdóttir, S.; Gillberg, C. Autism, ADHD, intellectual disability and behavior problems in 22q11 deletion syndrome. Res. Dev. Disabil. 2009, 30, 763–773. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization (WHO). International Classification of Functioning, Disability and Health (ICF), 1st ed.; World Health Organization Collaborating Centre for the Family of International Classifications in Portuguese; University of São Paulo Press: São Paulo, Brazil, 2008. [Google Scholar]
- Antshel, K.M.; Abdulsabur, N.; Roizen, N.; Fremont, W.; Kates, W.R. Sex differences in cognitive functioning in velocardiofacial syndrome. Dev. Neuropsychol. 2005, 28, 849–869. [Google Scholar] [CrossRef]
- Dewulf, D.; Noens, I.; Swillen, A. Adaptive skills, cognitive functioning and behavioural problems in adolescents with 22q11.2 deletion syndrome. Tijdschr. Psychiatr. 2013, 55, 369–374. [Google Scholar] [PubMed]
- Wallin, L.; Gillberg, C.; Knutsson, J.; Fernell, E.; Gillberg, I.C.; Billstedt, E. Cognitive, visuomotor and adaptive functioning in 22q11.2 deletion syndrome: A longitudinal study. Brain Behav. 2025, 15, e70638. [Google Scholar] [CrossRef]
- Angkustsiri, K.; Leckliter, I.; Tartaglia, N.; Beaton, E.A.; Enriquez, J.; Simon, T.J. Anxiety, intelligence and adaptive functioning in children with chromosome 22q11.2 deletion syndrome. J. Dev. Behav. Pediatr. 2012, 33, 713–721. [Google Scholar] [CrossRef] [PubMed]
- Vingerhoets, C.; Ruiz-Fernandez, J.; Scheibler, E.; Vergaelen, E.; Volbragt, N.; Soons, N.; Serrarens, C.; Vogels, A.; Boot, E.; van Amelsvoort, T.; et al. Cognitive, adaptive and daily life functioning in adults with 22q11.2 deletion syndrome. BJPsych Open 2024, 10, e203. [Google Scholar] [CrossRef] [PubMed]
- ABEP. Critério de Classificação Econômica Brasil; Associação Brasileira de Empresas de Pesquisa: São Paulo, Brazil, 2008. [Google Scholar]
- Bayley, N. Bayley Scales of Infant and Toddler Development, 3rd ed.; Pearson Clinical: São Paulo, Brazil, 2017. [Google Scholar]
- Laros, J.A.; Tellegen, P.J.; Jesus, G.R.; Karino, C.A. SON-R 2½–7[a]: Nonverbal Intelligence Test—Brazilian Standardization; Hogrefe CETEPP: São Paulo, Brazil, 2015. [Google Scholar]
- Wechsler, D. Wechsler Abbreviated Scale of Intelligence (WASI): Manual; Casa do Psicólogo: São Paulo, Brazil, 2014. [Google Scholar]
- Wechsler, D. Wechsler Intelligence Scale for Children—Fourth Edition (WISC-IV): Administration and Scoring Manual; Casa do Psicólogo: São Paulo, Brazil, 2013. [Google Scholar]
- Sparrow, S.S.; Cicchetti, D.V.; Balla, D.A. Vineland Adaptive Behavior Scales, 2nd ed.; Pearson: Circle Pines, MN, USA, 2016. [Google Scholar]
- Sparrow, S.S.; Cicchetti, D.V.; Saulnier, C.A. Vineland Adaptive Behavior Scales, 3rd ed.; Pearson Clinical: São Paulo, Brazil, 2019. [Google Scholar]
- Achenbach, T.M.; Ruffle, T.M. The Child Behavior Checklist and related forms. Pediatr. Rev. 2000, 21, 265–271. [Google Scholar] [CrossRef]
- Hosmer, D.W.; Lemeshow, S.; Sturdivant, R.X. Applied Logistic Regression, 3rd ed.; Wiley: Hoboken, NJ, USA, 2013. [Google Scholar]
- Pimenta, L.S.E. Neurocognitive and Behavioral Phenotype of 22q11.2 Deletion Syndrome. Ph.D. Thesis, University of São Paulo, São Paulo, Brazil, 2019. [Google Scholar]
- Pimenta, L.S.E.; Mello, C.B.; Benedetto, L.M.D.; Soares, D.C.Q.; Kulikowski, L.D.; Dantas, A.G.; Melaragno, M.I.; Kim, C.A. Neuropsychological profile of Brazilian patients with 22q11.2 deletion syndrome. Genes 2024, 15, 1099. [Google Scholar] [CrossRef]
- Cheung, E.N.M.; George, S.R.; Andrade, D.M.; Chow, E.W.C.; Silversides, C.K.; Bassett, A.S. Neonatal hypocalcemia and neurodevelopmental outcome in 22q11.2 deletion syndrome. Genet. Med. 2014, 16, 40–44. [Google Scholar] [CrossRef]
- White, L.K.; Crowley, T.B.; Finucane, B.; Garcia-Minaur, S.; Repetto, G.M.; van den Bree, M.; Fischer, M.; Jacquemont, S.; Barzilay, R.; Maillard, A.M.; et al. Impact of the COVID-19 pandemic in individuals with 22q11.2 copy number variants. J. Intellect. Disabil. Res. 2022, 66, 313–323. [Google Scholar] [CrossRef]
- Bassett, A.S.; McDonald-McGinn, D.M.; Devriendt, K.; Digilio, M.C.; Goldenberg, P.; Habel, A.; Marino, B.; Oskarsdottir, S.; Philip, N.; Sullivan, K.; et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J. Pediatr. 2011, 159, 332–339. [Google Scholar] [CrossRef] [PubMed]
- Snihirova, Y.; Linden, D.E.J.; van Amelsvoort, T.; van der Meer, D. Environmental influences on mental health in 22q11.2 deletion syndrome. Genes 2022, 13, 1936. [Google Scholar] [CrossRef]
- Shashi, V.; Veerapandiyan, A.; Schoch, K.; Kwapil, T.; Keshavan, M.; Ip, E.; Hooper, S. Social skills and psychopathology in children with chromosome 22q11.2 deletion syndrome. J. Intellect. Disabil. Res. 2012, 56, 865–878. [Google Scholar] [CrossRef]
- Debbané, M.; Glaser, B.; David, M.K.; Feinstein, C.; Eliez, S. Psychotic symptoms in youth with 22q11.2 deletion syndrome. Schizophr. Res. 2006, 84, 187–193. [Google Scholar] [CrossRef]
| Sociodemographic Variables | Min/Max | Mean ± SD | Median |
|---|---|---|---|
| Age | 01/17 | 11.5 ± 4.6 | 13.0 |
| N | % | ||
| Type of school Public Private No attending school | 10 11 03 | 59 35 09 | |
| No literate | 06 | 35 | |
| Special educational support | 17 | 50 | |
| Caretaker years of schooling Elementary School I Elementary School II High School Higher education Family socioeconomic classification A B C D | 01 05 13 14 07 12 15 05 | 3 18 38 41 21 32 32 14 | |
| Clinical variables | N | % | |
| Pregnancy problems | 09 | 27 | |
| Neonatal complications | 17 | 50 | |
| Health problems * | 29 | 85 | |
| Developmental delay | 28 | 82 | |
| Maxillofacial abnormalities | 11 | 32 | |
| Congenital heart disease | 24 | 71 | |
| Neurological problems | 07 | 21 | |
| Use of psychotropic medication | 11 | 32 | |
| Multidisciplinary follow-up | 18 | 53 | |
| Variáveis | N | Min/Max | Mean ± SD | Median |
|---|---|---|---|---|
| FSIQ_WISC_WASI | 27 | 45/105 | 69.3 ± 15.4 | 68.0 |
| Nonverbal FSIQ_Son_R | 2 | 52/59 | 55.5 ± 5.0 | 55.5 |
| Cognitive domain_Bayley | 2 | 75/90 | 82.5 ± 10.6 | 82.0 |
| G.A.F._VABS | 32 | 47/125 | 70.4 ± 16.1 | 66.5 |
| COM._VABS | 32 | 41/102 | 66.7 ± 14.3 | 65.0 |
| D.L.S._VABS | 32 | 29/125 | 69.9 ± 20.2 | 66.5 |
| SOC._VABS | 32 | 43/135 | 73.1 ± 19.9 | 60.0 |
| MOT._VABS | 08 | 47/125 | 61.4 ± 16.6 | 60.0 |
| Anxious_CBCL | 28 | 51/83 | 63.1 ± 9.3 | 63.1 |
| Withdrawn__CBCL | 28 | 50/100 | 67.1 ± 14.1 | 67.1 |
| Simatic__CBCL | 28 | 32/82 | 60.1 ± 10.6 | 60.1 |
| Rule-Breaking.__CBCL | 28 | 50/71 | 57.9 ± 6.8 | 57.9 |
| Agressive Beha.__CBCL | 28 | 50/76 | 59.4 ± 8.1 | 59.4 |
| Social Probl.__CBCL | 28 | 54/88 | 66.6 ± 9.5 | 66.6 |
| Thought Probl.__CBCL | 28 | 50/78 | 63.6 ± 8.3 | 63.6 |
| Attention Probl.__CBCL | 28 | 52/93 | 67.9 ± 10.5 | 67.5 |
| Variables | B | ES | p | CI 95% |
|---|---|---|---|---|
| FSIQ a | ||||
| Sociodemographic variables | ||||
| Type of school | 10.96 | 9.61 | 0.271 | (−10.28/27.65) |
| Literate | 9.48 | 6.14 | 0.120 | (−4.59/20.11) |
| Family social class | −0.53 | 4.58 | 0.908 | (−9.21/8.59) |
| Clinical variables | ||||
| Developmental delay | −13.06 | 13.36 | 0.479 | (−33.87/7.59) |
| Neurological problems | −12.94 | 7.49 | 0.088 | (−25.68/−0.20) |
| GAF b | ||||
| Sociodemografic variables | ||||
| Special educational support | −12.54 | 5.11 | 0.031 | (−23.05/−3.00) |
| Family social class | −6.83 | 2.46 | 0.023 | (−11.66/−1.79) |
| Clinical variables | ||||
| Health problems | −15.12 | 12.63 | 0.256 | (−42.17/7.00) |
| Developmental delay | −9.65 | 5.88 | 0.114 | (−20.57/2.64) |
| Use of psychotropic medication | −4.12 | 4.26 | 0.353 | (−13.16/4.15) |
| Variables | B | SE | p | CI 95% |
|---|---|---|---|---|
| Anxious a | ||||
| Sociodemographic variables | ||||
| Gender | 4.81 | 3.77 | 0.210 | (−3.06/12.09) |
| Family social class | −2.90 | 1.78 | 0.125 | (−6.45/0.48) |
| Clinical variables | ||||
| Inherited deletion | −4.00 | 3.03 | 0.166 | (−8.50/2.75) |
| Neurological problems | −4.04 | 3.75 | 0.299 | (−11.77/2.51) |
| Withdrawn b | ||||
| Sociodemographic variables | ||||
| Age | 1.95 | 0.53 | <0.001 | (0.95/2.99) |
| Clinical variables | ||||
| Congenital heart disease | −13.16 | 6.03 | 0.050 | (−25.09/−0.97) |
| Use of psychotropic medication | −5.76 | 5.46 | 0.302 | (−16.11/5.28) |
| Somatic c | ||||
| Sociodemographic variables | ||||
| Age | 0.49 | 0.75 | 0.507 | (−0.92/2.12) |
| Literate | 10.89 | 6.51 | 0.090 | (−1.42/23.50) |
| Clinical variables | ||||
| Inherited deletion | −18.00 | 9.81 | 0.083 | (−36.85/1.19) |
| Pregnancy problems | −2.92 | 4.12 | 0.506 | (−11.77/4.09) |
| Neurological problems | −0.45 | 4.20 | 0.926 | (−8.30/8.00) |
| Social Problems d | ||||
| Clinical variables | ||||
| Inherited deletion | 9.98 | 5.99 | 0.076 | (1.00/23.00) |
| Congenital heart disease | −7.69 | 4.72 | 0.119 | (−16.35/2.30) |
| Thought Problems e | ||||
| Sociodemographic variables | ||||
| Gender | 5.13 | 2.73 | 0.071 | (0.17/10.86) |
| Type of school | −0.28 | 3.94 | 0.946 | (−8.63/7.14) |
| Family social class | −4.17 | 1.87 | 0.033 | (−7.61/−0.14) |
| Clinical variables | ||||
| Health problems | 4.44 | 3.23 | 0.165 | (−2.53/10.38) |
| Attention Problems f | ||||
| Sociodemographic variables | ||||
| Gender | 10.75 | 3.74 | 0.017 | (3.64/18.14) |
| Clinical variables | ||||
| Congenital heart disease | −7.77 | 6.25 | 0.237 | (−20.62/4.08) |
| Neurological problems | −9.90 | 5.68 | 0.096 | (−20.98/1.56) |
| Variables | B | SE | p | CI 95% |
|---|---|---|---|---|
| GAF a | ||||
| Social Problems | −0.71 | 0.35 | 0.055 | (−1.45/−0.09) |
| Adaptive Functioning—Communication b | ||||
| Social Problems | −0.51 | 0.30 | 0.103 | (−1.04/0.15) |
| Adaptive Functioning—Socialization c | ||||
| Social Problems | −0.73 | 0.64 | 0.278 | (−2.09/0.41) |
| Attention Problems | −0.08 | 0.55 | 0.870 | (−0.81/1.37) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Pimenta, L.S.E.; Mello, C.B.d.; Polanczyk, G.V.; Kulikowski, L.D.; Melaragno, M.I.; Kim, C.A. Adaptive and Behavioral Phenotype in Pediatric 22q11.2 Deletion Syndrome: Characterizing a High-Risk Neurogenetic Copy Number Variant. Genes 2026, 17, 120. https://doi.org/10.3390/genes17020120
Pimenta LSE, Mello CBd, Polanczyk GV, Kulikowski LD, Melaragno MI, Kim CA. Adaptive and Behavioral Phenotype in Pediatric 22q11.2 Deletion Syndrome: Characterizing a High-Risk Neurogenetic Copy Number Variant. Genes. 2026; 17(2):120. https://doi.org/10.3390/genes17020120
Chicago/Turabian StylePimenta, Larissa Salustiano Evangelista, Claudia Berlim de Mello, Guilherme V. Polanczyk, Leslie Domenici Kulikowski, Maria Isabel Melaragno, and Chong Ae Kim. 2026. "Adaptive and Behavioral Phenotype in Pediatric 22q11.2 Deletion Syndrome: Characterizing a High-Risk Neurogenetic Copy Number Variant" Genes 17, no. 2: 120. https://doi.org/10.3390/genes17020120
APA StylePimenta, L. S. E., Mello, C. B. d., Polanczyk, G. V., Kulikowski, L. D., Melaragno, M. I., & Kim, C. A. (2026). Adaptive and Behavioral Phenotype in Pediatric 22q11.2 Deletion Syndrome: Characterizing a High-Risk Neurogenetic Copy Number Variant. Genes, 17(2), 120. https://doi.org/10.3390/genes17020120

